Mr Shane Albright > Goodwin > Silicon Valley, United States > Lawyer Profile
Goodwin Offices
601 Marshall Street
Redwood City, CA 94063
CALIFORNIA
United States
- Firm Profile
- Go to...
Mr Shane Albright
Position
Partner
Career
Shane Albright is a partner in the firm’s Life Sciences group. Mr. Albright represents life science and technology companies in a wide range of corporate, financial and commercial matters, with a particular emphasis on complex transactions involving intellectual property. He has extensive experience counseling clients on corporate partnering issues, strategic alliances, technology licenses and key commercial contracts, such as manufacturing and distribution agreements.
Mr. Albright regularly provides advice on licensing and commercial contract issues in connection with mergers and acquisitions, IPOs and other public financings. He also represents emerging growth companies and their investors in venture financings, other funding transactions and general corporate matters. Mr. Albright’s clients include companies in the biopharmaceutical, medical device, diagnostics, hardware, software, medical instrumentation, digital health, vaccine and research reagent spaces, as well as entities that fund or conduct medical research.
Education
J.D., 2002 Stanford Law School (with distinction) Ph.D., Molecular and Cell Biology, 1999 University of California, Berkeley B.S., Biological Sciences, 1991 Stanford University (with distinction)
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)